Literature DB >> 24377559

Treatment outcome with brachytherapy for recurrent nasopharyngeal carcinoma.

Soon Keat Cheah1, Fen Nee Lau, Mastura Md Yusof, Vincent Chee Ee Phua.   

Abstract

BACKGROUND: To evaluate the treatment outcome and major late complications of all patients with recurrent nasopharyngeal carcinoma (NPC) treated with intracavitary brachytherapy (ICBT) in Hospital Kuala Lumpur.
MATERIALS AND METHODS: This retrospective study was conducted at the Department of Radiotherapy and Oncology, Hospital Kuala Lumpur, Malaysia. All patients with histologically confirmed recurrent NPC in the absence of distant metastasis treated in the period 1997-2010 were included in this study. These patients were treated with ICBT alone or in combination with external beam radiotherapy (EBRT). Treatment outcomes measured were local recurrence free survival (LRFS), disease free survival (DFS) and overall survival (OS).
RESULTS: Thirty three patients were eligible for this study. The median age at recurrence was 56 years with a median time to initial local recurrence of 27 months. Majority of patients were staged as rT1-2 (94%) or rN0 (82%). The proportion of patients categorised as stage III-IV at first local recurrence was only 9%. Twenty one patients received a combination of ICBT and external beam radiotherapy while 12 patients were treated with ICBT alone. Median interval of recurrence post re-irradiation was 32 months (range: 4-110 months). The median LRFS, DFS and OS were 30 months, 29 months and 36 months respectively. The 5 year LRFS, DFS and OS were 44.7%, 38.8% and 28.1% respectively. The N stage at recurrence was found to be a significant prognostic factor for LRFS and DFS after multivariate analysis. Major late complications occurred in 34.9% of our patients.
CONCLUSIONS: Our study shows ICBT was associated with a reasonable long term outcome in salvaging recurrent NPC although major complications remained a significant problem. The N stage at recurrence was a significant prognostic factor for both LRFS and DFS.

Entities:  

Mesh:

Year:  2014        PMID: 24377559     DOI: 10.7314/apjcp.2013.14.11.6513

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

2.  Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.

Authors:  Sufang Qiu; Jun Lu; Wei Zheng; Luying Xu; Shaojun Lin; Chaobin Huang; Yuanji Xu; Lingling Huang; Jianji Pan
Journal:  BMC Cancer       Date:  2014-11-03       Impact factor: 4.430

3.  Chemotherapy use and survival in stage II nasopharyngeal carcinoma.

Authors:  Xin-Bin Pan; Shi-Ting Huang; Kai-Hua Chen; Xiao-Dong Zhu
Journal:  Oncotarget       Date:  2017-10-11

4.  CT-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma.

Authors:  Huzheng Yan; Zhiqiang Mo; Zhanwang Xiang; Dailin Rong; Yanlin Zhang; Guanyu Chen; Zhihui Zhong; Fujun Zhang; Fei Gao
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

5.  Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.

Authors:  Ryan Anthony F Agas; Kelvin Ken L Yu; Paolo G Sogono; Lester Bryan A Co; J C Kennetth M Jacinto; Warren R Bacorro; Michael Benedict A Mejia
Journal:  J Glob Oncol       Date:  2019-02

6.  Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.

Authors:  Lu Ping Tan; Geok Wee Tan; Vijaya Mohan Sivanesan; Siang Ling Goh; Xun Jin Ng; Chun Shen Lim; Wee Ric Kim; Taznim Begam Binti Mohd Mohidin; Nor Soleha Mohd Dali; Siew Hoon Ong; Chun Ying Wong; Halimuddin Sawali; Yoke Yeow Yap; Faridah Hassan; Kin Choo Pua; Cheng Eng Koay; Ching Ching Ng; Alan Soo-Beng Khoo
Journal:  Int J Cancer       Date:  2019-10-08       Impact factor: 7.396

Review 7.  Nasopharyngeal carcinoma: A new synthesis of literature data (Review).

Authors:  Daniela Jicman Stan; Elena Niculet; Mihaela Lungu; Cristian Onisor; Laura Rebegea; Doinita Vesa; Laura Bezman; Florin Ciprian Bujoreanu; Mihaela Ionela Sarbu; Raul Mihailov; Silvia Fotea; Alin Laurentiu Tatu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.